School of Medicine
Showing 1-50 of 82 Results
-
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
On Leave from 08/05/2024 To 12/13/2024Current Research and Scholarly InterestsCurrent research projects include:
1) PET/MRI and PET/CT for Early Cancer Detection
2) Targeted Radionuclide Therapy
3) Clinical Translation of Novel PET Radiopharmaceuticals; -
David Iberri
Clinical Assistant Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Hirotaka Ieki
Postdoctoral Scholar, Genetics
BioCardiologist in Japan.
Research interest: precision medicine in cardiovascular disease. Genomics, Exposomics. -
Irogue I Igbinosa
Instructor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioIrogue Igbinosa, MD, MS, is a Maternal-Fetal Medicine physician at Stanford University. She is currently an NIH Women's Reproductive Health Scholar (K12), and her research focus includes iron deficiency anemia in pregnancy, severe maternal morbidity and mortality, and health equity.
She graduated from the University of Houston and earned her medical degree at Baylor College of Medicine. She subsequently completed her residency in Obstetrics and Gynecology Residency at Louisiana State University School of Medicine Baton Rouge. After residency, she was an AAMC-CDC Public Health Policy Fellow able to serve in the CDC Emergency Operations Center and contribute to research for healthcare providers regarding the management of the Zika virus in pregnant persons. She completed her Maternal Fetal Medicine fellowship at Stanford in 2022.
Dr. Igbinosa is passionate about community-engaged approaches to bridge gaps in evidence-based care for birthing communities and collaborates with local and national policy committees to raise awareness for reproductive justice in maternal health. Her motto is to listen first and serve with compassion. -
Debra M. Ikeda, M.D.
Professor of Radiology (Breast Imaging), Emerita
Current Research and Scholarly InterestsMy research interests are mammography positioning, tomosynthesis (DBT) cancer detection and diagnosis, MRI, DWI, MRI-guided breast biopsy, breast cancer recurrence, tattoo/ fiducial/wire localization of axillary lymph nodes, breast cancer and FDG PET-CT imaging, artifical intelligence/deep learning, breast density, density notification legislation, COVID-19 effects on Breast Imaging Centers and personnel
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Jennifer Ikle
Adjunct Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes
Current Research and Scholarly InterestsJen is interested in the genetic factors that lead to abnormal beta-cell function and insulin secretion, causing disorders such as hyperinsulinism and neonatal diabetes. Jen’s current research focus is the use of zebrafish models, combined with genetics and genomics, to understand cellular and molecular mechanisms of glucose metabolism and elucidate previously unknown players involved in the regulation of insulin secretion.
-
iva sikirica ilic
Adjunct Clinical Instructor, Educational Programs and Services (EPS)
BioIva Ilic, MD, is a board certified family physician with extensive experience as a hospitalist. She has a special interest in women's health, small office procedures and preventative care.
In her spare time, she hikes with her husband, and plays the piano. -
Yuki Imaoka
Visiting Assistant Professor, Surgery - Abdominal Transplantation
BioYuki Imaoka, MD, PhD is a physician-scientist specializing in gastrointestinal and transplant surgery, oncology, and immunology, with over a decade of clinical experience. Dr. Imaoka earned his MD from Hiroshima University, Japan, followed by a PhD in Gastroenterological and Transplant Surgery from Hiroshima University's Graduate School of Biomedical and Health Sciences. After completing his clinical training and professional appointments at Hiroshima University Hospital, he joined Stanford University in August 2022 as a Visiting Assistant Professor in the Sasaki Lab, focusing on translational research.
Dr. Imaoka’s clinical expertise includes a Senior Residency in General Surgery and a Clinical Fellowship in Gastroenterological and Transplant Surgery at Hiroshima University Hospital. In his academic roles, particularly as an Assistant Professor in the Department of Gastroenterological and Transplant Surgery, he has contributed to groundbreaking research, including clinical trials investigating liver natural killer (NK) cell therapy.
His PhD research made significant advances in exploring the anti-tumor properties of NK cells, especially in the context of tissue-specific NK cell immunotherapy. This work has the potential to revolutionize treatments for liver diseases, as it pioneers new pathways in cellular immunotherapy. Dr. Imaoka’s translational research seeks to address the unmet needs in liver disease treatment, with a focus on improving patient outcomes through innovative therapeutic approaches. His goal is to continue advancing the field of gastrointestinal surgery and transplantation, driving progress in both research and clinical practice. -
Daniel Imler
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsI am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.
-
Hiroyuki Inoue
Postdoctoral Scholar, Cardiovascular Medicine
BioPhysician-scientist passionate about bridging research findings and clinical practice
- Board certified cardiologist with 10+ years clinical experience, focused on cardiovascular diseases including heart failure, ischemic heart disease, arrhythmia, and general internal medicine
- Experience of 400+ cases as the primary operator in percutaneous coronary intervention, catheter ablation, and cardiac device implantation
- Research expertise in extracelluler vesicles, regenerative medicine, genome editing and gene therapy
Dr. Inoue joined the Yang lab in 2022. His research aim is the development of novel regenerative therapeutics for heart failure. -
Alexander Ioannidis
Affiliate, Biomedical Data Science
Adjunct Professor, Institute for Computational and Mathematical Engineering (ICME)BioDr. Alexander Ioannidis is an Adjunct Professor in Computational and Mathematical Engineering, where he teaches machine learning and data science, and is a researcher in the Department of Biomedical Data Science at Stanford Medical School. He earned his Ph.D. from Stanford University in Computational and Mathematical Engineering together with an M.S. in Management Science and Engineering (Optimization). He graduated summa cum laude from Harvard University in Chemistry and Physics and earned an M.Phil at the University of Cambridge from the Department of Applied Math and Theoretical Physics in Computational Biology. His research focuses on the design of algorithms and application of computational methods for problems in genomics, clinical data science, and precision health with a particular focus on underrepresented populations in Oceania and Latin America.
*For John Ioannidis (no relation), see here, https://profiles.stanford.edu/john-ioannidis -
John P.A. Ioannidis
Professor of Medicine (Stanford Prevention Research), of Epidemiology and Population Health and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Eric Ip
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhancing drugs.
-
Wui Ip, MD
Clinical Assistant Professor, Pediatrics
BioWui Ip, MD is a pediatrician and physician informaticist. He is interested in applying machine learning to support clinical decision making and improve patient care.
-
Negaur Iranpour, MD
Clinical Instructor, Radiology
BioDr. Iranpour is a board-certified, fellowship-trained radiologist with Stanford Health Care Radiology. She is also a clinical instructor in the Department of Radiology at Stanford University School of Medicine.
Dr. Iranpour’s practice focuses on image-guided interventions for a variety of conditions including cancers, tumors, and lesions. She treats a wide range of health concerns, including cancer pain, endometriosis, prostate cancer, soft tissue tumors, uterine fibroids, and Parkinson’s disease.
Dr. Iranpour’s research interests include using abdominal MRIs to evaluate liver lesions and studying the features of pancreatic cysts. She also studies the use of MRI-guided prostate ablation and cryoablation for desmoid tumors (noncancerous growths in connective tissues).
Dr. Iranpour has been published in many peer-reviewed journals, including Abdominal Radiology, Human Psychopharmacology: Clinical and Experimental, and the Asian Pacific Journal of Cancer Prevention. She has also presented her work at national and international meetings, including at the International Society for Magnetic Resonance in Medicine, the Society of Abdominal Radiology, and the American Public Health Association. Her papers and presentations have won awards, including at the 1st Basic and Clinical Neuroscience Congress in Iran.
Dr. Iranpour is a member of the American Board of Radiology, the American College of Radiology, and the Society of Abdominal Radiology. She is also a member of the Radiological Society of North America and the International Society for Magnetic Resonance in Medicine. -
Nicole Irgens-Moller
Clinical Assistant Professor, Emergency Medicine
Clinical Assistant Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsAssociation of Race and Insurance on Social Work Consults and Child Protective Services Reports following Ingestions in Young Children. [Platform Presentation]. Ray E. Helfer Society Conference, 2024, Savannah, GA, United States
-
Cynthia Irvine
Associate Dean, Office of Medical Education, School of Medicine - Student Affairs
Current Role at StanfordAssociate Dean, Office of Medical Education (MD Program)
